Vanda Pharmaceuticals (VNDA) Reports Q1 EPS of $0.06
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.80 --0%
EPS Growth %: -30.4%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.4%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.06. Revenue for the quarter came in at $62.5 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Robinhood plans $2B convertible notes offering due 2029
- AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
